×

PMDA

shutterstock_552100717

Japan renews its participation in MDSAP until 2020

By Luis Jimenez | 05.02.2019
Japan’s participation in MDSAP (Medical Device Standardized Audit Program) has been a contributing factor in the exponential update of MDSAP by multinational companies. Japan’s MHLW and PMDA has been opting...
Brandwood Biomedical global experts medical devices regulatory affairs consulting medical devices IVDs Brandwood Biomedical Global Expertise in Medical Device Regulatory Compliance Australia China Taiwan Hong Kong Europe New Zealand United States

Australia via 510(k): TGA – recognises US, Canadian and Japanese approvals with MDSAP

By Arthur Brandwood | 08.30.2018
Australia’s regulatory system is modelled very closely on that of Europe. This equivalence of requirements and assessment pathways has allowed TGA to leverage prior CE marking to grant Australian device...

Search

Recent Posts

Cybersecurity – Is Your Device Software Secure?

Aug 13, 2019

Inaugural Course on Molecular Toxicology

Aug 5, 2019

Beyond a business merger, diverse skills come together at Brandwood CKC

Aug 5, 2019

Applications Closing Soon – November PL.

Aug 1, 2019

Importance of Innovation

Jul 29, 2019

And so starts the MDR/Brexit fallout… First LRQA and now QS Zurich fall by the wayside

Jun 27, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 3D printing 510(k) 510(k) PMA adverse events Apple Watch Artificial Intelligence Australia Biocompatibility Biomechanics Brexit CE CE Certificates CFDA China clinical evidence de novo distribution Europe FDA Health Canada IVD IVDR MDR MDSAP mechanical properties medical device medical devices New Zealand Notified Bodies PMA PMDA postmarket post market premarket Quality Systems Reform regulatory Reimbursement SaMD Software standards Sterilisation TGA Webinar
Translate »